News Archive
A new study by researchers at The George Washington University School of Medicine and Health Sciences' Department of Biochemistry and Molecular Biology raises hope that autism may be more easily diagnosed and that its effects may be more reversible than previously thought.
Biosign Technologies Inc. announced today the closing of a brokered private placement of units of the Company for gross proceeds of approximately $1,900,000.
Allos Therapeutics has announced the presentation of new findings from its Phase 3 clinical trial of the investigational radiation sensitizer Efaproxyn (efaproxiral) in patients with brain metastases.
Adolescents with posttraumatic stress disorder (PTSD) symptoms are more likely to misidentify sad and angry faces as fearful, while teens with symptoms of conduct disorder tend to interpret sad faces as angry, finds a study by NYU's Steinhardt School of Culture, Education, and Human Development.
› Verified 2 days ago